and PCT non-provisional applications, and 14 pending foreign national applications, including applications in Australia, Brazil, Canada, China, Europe, Israel, Japan, Korea, Mexico, New Zealand, Singapore and Taiwan
Their potential effects on cardiovascular health, liver disease, neurodegeneration, and mental health highlight a shift towards more integrated and system-wide approaches to therapy
Cardiovascular Benefits Beyond shedding pounds, these drugs also support heart health
Importantly, Lillys overall portfolio is balanced (including diabetes, oncology, and immunology drugs), which gives it financial muscle to support aggressive marketing of its new obesity drugs